| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21.929 | 0 | 0 |
| Total Expenses - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.651 | 1 | 0 |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13.278 | -1 | 0 |
| Net Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.621 | -1 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Sanowell Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.925 | 5.865 | 5.766 | 5.660 | 5.550 | 5.445 | 5.324 | 0 | 0 | 0 |
| Current Assets | 2.463 | 2.438 | 2.396 | 2.352 | 2.307 | 2.263 | 2.213 | 2.156 | 1.932 | 1.921 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.339 | 2.316 | 2.276 | 2.235 | 2.191 | 2.263 | 2.102 | 2.044 | 1.883 | 1.872 |
| Cash | 123 | 122 | 120 | 118 | 115 | 0 | 111 | 111 | 49 | 49 |
| Shareholders Funds | -12.340 | -12.214 | -12.008 | -11.787 | -11.559 | -11.340 | -11.088 | 1.498 | 1.492 | 1.483 |
| Social Capital | 1.215 | 1.202 | 1.182 | 1.160 | 1.138 | 1.116 | 1.092 | 1.095 | 1.092 | 1.086 |
| Debts | 20.728 | 20.517 | 20.170 | 19.800 | 19.416 | 19.048 | 18.626 | 658 | 440 | 438 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9604 - 9604" | |||||||||
| CAEN Financial Year |
9604
|
|||||||||
Comments - Sanowell Srl